Jun. 26 at 9:11 AM
$ATAI i mean theres only 3 trading days left in the month.
2 read outs expected any moment.
What if both are stellar? Could add billions to the market cap immediately.
Seems like management has tempered expectations for RL007. It appears not much efficacy but who knows? This phase 2b could show improvement. No drug has been able to do anything for over 20 years. Huge pharma tried and failed. So no one is expecting anything from RL007.
BP003 is the lead candidate and if good data, will totally outshine RL007. It wont matter. Its almost like ATAI has a call option on RL007. If it works out, fantastic. If not, no big deal.
If BP003 has big numbers, over 5 at least, and RL007 is good enough to go to phase 3....then youre talking massive upgrades and revaluations.
I guess bottom line, I will be loading the coffers.
